© 2022 BioMarin. All rights reserved.

Independent Research Presented at Pediatric Endocrine Society Annual Meeting

News | May 1, 2022

BioMarin congratulates Dr. Andrew Dauber, Chief of Endocrinology at Children’s National Hospital in Washington, D.C., who has recently presented independent research to study a BioMarin therapy, in selected genetic causes of short stature. Dr. Dauber presented preliminary findings at the Pediatric Endocrine Society (PES) Annual Meeting on Sunday, May 1. For more information on Dr. Dauber’s research, please click here.